Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating γδ T cell therapy for hepatocellular carcinoma has completed with reported safety and efficacy signals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• T-cell therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED